about
Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study.Nongenomic effects of mineralocorticoid receptor activation in the cardiovascular system.Nongenomic actions of aldosterone: physiological or pathophysiological role?Aldosterone and mineralocorticoid receptors: Clinical studies and basic biology.Rationale and design of a randomized trial on the impact of aldosterone antagonism on cardiac structure and function in diabetic cardiomyopathy.Aldosterone in heart disease.Low-dose spironolactone prevents apoptosis repressor with caspase recruitment domain degradation during myocardial infarction.Inflammatory and thrombotic changes in early bereavement: a prospective evaluation.Rapid, nongenomic effects of aldosterone in the heart mediated by epsilon protein kinase C.Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction.Mineralocorticoid and angiotensin receptor antagonism during hyperaldosteronemia.Introduction: Aldosterone and salt: heart and kidney.Nongenomic cardiovascular actions of aldosterone: a receptor for all seasons?Prospective study of early bereavement on psychological and behavioural cardiac risk factors.Effect of early bereavement on heart rate and heart rate variability.Haemodynamic changes during early bereavement: potential contribution to increased cardiovascular risk.Ambulatory blood pressure monitoring in AustraliaHigh-dose insulin in experimental myocardial infarction in rabbits: protection against effects of hyperglycaemiaHMG CoA reductase inhibition reduces sarcolemmal Na+–K+ pump densityPsychological symptom profiles in patients with chest pain
P50
Q33790456-A3CD4396-8CC4-4E13-8E9C-AAA306CF30F0Q34414960-8BFA2176-EEB0-44CF-9B41-E63356B836C2Q36310155-1DFEFED1-B429-450F-BC52-D9B68A2BB942Q37332262-8282D0E0-5CB2-472E-8DF6-FC9FCDBA3B97Q37363507-FD4B81E9-02C0-48B7-B3F9-AB8BB3A1D8D2Q37981980-B6A3D577-AA55-4562-A181-D475DFAFF817Q39363680-27B5734A-D8D7-4924-8C06-9C7137FDCE84Q39709798-A6743A76-8758-4358-9ED2-C4AAF892CD36Q42452403-BD31C0B3-BC89-445E-98B8-FF7567A1FB4BQ43258606-B68390B0-7E39-406E-93AF-91239ACE40D4Q44087056-C867486C-E13F-4A0B-A477-49FACF125EDEQ44566109-64CE18EA-AABA-4241-9464-F1D885292C7FQ45267537-F37FA253-ED04-40B2-B8A1-FF3094650337Q46002192-1F7B0544-4ADE-4BC3-AFED-D9CAD84CBED1Q50565097-CFEF913D-B4E0-4364-A7F2-E568D8BD834EQ50654240-FA3B8136-FAFE-4E04-9F16-D484EED07F42Q60563908-EAA35976-92AD-4A60-BC2D-38DD0B33D27DQ60563930-14481BB1-0A3A-49BE-AFC0-FC5450F11FC3Q60563957-33E4A7CA-6823-461F-B649-CDF584F0E9B0Q60563970-FBE3144A-F671-4A08-B156-B62E09F0D9DD
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Anastasia S Mihailidou
@nl
Anastasia S Mihailidou
@sl
Anastasia S. Mihailidou
@en
Anastasia S. Mihailidou
@es
type
label
Anastasia S Mihailidou
@nl
Anastasia S Mihailidou
@sl
Anastasia S. Mihailidou
@en
Anastasia S. Mihailidou
@es
prefLabel
Anastasia S Mihailidou
@nl
Anastasia S Mihailidou
@sl
Anastasia S. Mihailidou
@en
Anastasia S. Mihailidou
@es
P1053
G-3999-2013
P106
P1153
6603551875
P21
P31
P3829
P496
0000-0001-6435-0411